Grb2 signaling in cell motility and cancer
- 12 July 2008
- journal article
- review article
- Published by Taylor & Francis Ltd in Emerging Therapeutic Targets
- Vol. 12 (8), 1021-1033
- https://doi.org/10.1517/14728222.12.8.1021
Abstract
(2008). Grb2 signaling in cell motility and cancer. Expert Opinion on Therapeutic Targets: Vol. 12, No. 8, pp. 1021-1033.This publication has 127 references indexed in Scilit:
- The other side of MMPs: Protective roles in tumor progressionCancer and Metastasis Reviews, 2007
- Short-hairpin RNA-mediated stable silencing of Grb2 impairs cell growth and DNA synthesisBiochemical and Biophysical Research Communications, 2007
- Grb2‐SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxelInternational Journal of Cancer, 2007
- Inhibition of Shc/Grb2 protein–protein interaction suppresses growth of B104-1-1 tumors xenografted in nude miceLife Sciences, 2005
- The role of focal-adhesion kinase in cancer — a new therapeutic opportunityNature Reviews Cancer, 2005
- Focal adhesion kinase: in command and control of cell motilityNature Reviews Molecular Cell Biology, 2005
- Erk/Src Phosphorylation of Cortactin Acts as a Switch On-Switch Off Mechanism That Controls Its Ability To Activate N-WASPMolecular and Cellular Biology, 2004
- Cell adhesion and signalling by cadherins and Ig-CAMs in cancerNature Reviews Cancer, 2004
- The Hallmarks of CancerCell, 2000
- Regulation of Endothelial CD44 Expression and Endothelium–Tumour Cell Interactions by Hepatocyte Growth Factor/Scatter FactorBiochemical and Biophysical Research Communications, 1997